CD177 and cancer: These multifunctional molecules often act as cell surface receptors, are overexpressed in cancer, and represent potential immunotherapy targets [for example, ALCAM-CD166; melanoma CAM (MCAM)-CD146/Mucin 18, CXADR] (32–34).